Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective

(2015) Philipp Schuetz et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection

(2014) W.E. van derStarre et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically Ill Patients With Cancer*

(2014) Labib Debiane et al.   CRITICAL CARE MEDICINE

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

(2013) Andreas Hohn et al.   BMC INFECTIOUS DISEASES

Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies

(2013) Munirah Al Shuaibi et al.   CLINICAL INFECTIOUS DISEASES

Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis

(2013) Philipp Schuetz et al.   Current Opinion in Critical Care

Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission

(2013) B. Suberviola et al.   INTENSIVE CARE MEDICINE

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

(2013) Christina Wacker et al.   LANCET INFECTIOUS DISEASES

Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients

(2013) Sandra H. Hoeboer et al.   PLoS One

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score

(2012) Francesco Travaglino et al.   BMC INFECTIOUS DISEASES

Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis

(2012) Silvia Angeletti et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

(2010) Lila Bouadma et al.   LANCET

Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR®

(2009) Pascaline Caruhel et al.   CLINICAL BIOCHEMISTRY

Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections

(2009) Philipp Schuetz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

(2008) David T. Huang et al.   ANNALS OF EMERGENCY MEDICINE

Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care

(2008) Matthias Briel et al.   ARCHIVES OF INTERNAL MEDICINE

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

(2007) S. Kruger et al.   EUROPEAN RESPIRATORY JOURNAL